Clinical and immunological characterization of 14 cases of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a single-centre study

Br J Dermatol. 2020 Mar;182(3):806-807. doi: 10.1111/bjd.18516. Epub 2019 Nov 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
  • Humans
  • Hypoglycemic Agents
  • Non-Fibrillar Collagens
  • Pemphigoid, Bullous* / chemically induced

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Non-Fibrillar Collagens
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases